NCT00473694View on ClinicalTrials.gov

Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)

PHASE3CompletedINTERVENTIONAL

Enrollment

182

Participants

Timeline

Start Date

November 28, 2005

Primary Completion Date

November 6, 2006

Study Completion Date

January 29, 2007

Conditions

Anesthesia, General

Interventions

DRUG

sugammadex

Administered as an intravenous (IV) infusion

DRUG

neostigmine

Administered as an IV infusion

DRUG

vecuronium

Administered as an IV infusion

DRUG

rocuronium

Administered as an IV infusion

DRUG

glycopyrrolate

Administered as an IV infusion

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00473694 - Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025) | Biotech Hunter | Biotech Hunter